These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
577 related items for PubMed ID: 19421058
1. Neisseria meningitidis: epidemiology, treatment and prevention in adolescents. Brigham KS, Sandora TJ. Curr Opin Pediatr; 2009 Aug; 21(4):437-43. PubMed ID: 19421058 [Abstract] [Full Text] [Related]
2. Prevention of meningococcal disease. Kimmel SR. Am Fam Physician; 2005 Nov 15; 72(10):2049-56. PubMed ID: 16342836 [Abstract] [Full Text] [Related]
3. Serogroup B meningococcal vaccines. Zimmer SM, Stephens DS. Curr Opin Investig Drugs; 2006 Aug 15; 7(8):733-9. PubMed ID: 16955685 [Abstract] [Full Text] [Related]
4. Neisseria meningitidis B vaccines. Panatto D, Amicizia D, Lai PL, Gasparini R. Expert Rev Vaccines; 2011 Sep 15; 10(9):1337-51. PubMed ID: 21919622 [Abstract] [Full Text] [Related]
5. Meningococcal disease. Daley AJ. Aust Fam Physician; 2003 Aug 15; 32(8):597-601, 603-5. PubMed ID: 12973866 [Abstract] [Full Text] [Related]
6. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews. Prasad K, Karlupia N. Respir Med; 2007 Oct 15; 101(10):2037-43. PubMed ID: 17706408 [Abstract] [Full Text] [Related]
8. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results]. Levy C, Taha MK, Bingen E, Cohen R, Groupe des Pédiatres et Microbiologistes de l’Observatoire National des Meningites Bactériennes de l’Enfant. Arch Pediatr; 2012 Sep 15; 19 Suppl 2():S49-54. PubMed ID: 22883366 [Abstract] [Full Text] [Related]
15. Meningococcal disease: risk for international travellers and vaccine strategies. Wilder-Smith A. Travel Med Infect Dis; 2008 Jul 15; 6(4):182-6. PubMed ID: 18571105 [Abstract] [Full Text] [Related]
16. Quadrivalent meningococcal conjugate vaccines. Pace D, Pollard AJ, Messonier NE. Vaccine; 2009 Jun 24; 27 Suppl 2():B30-41. PubMed ID: 19477560 [Abstract] [Full Text] [Related]
17. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE, Active Bacterial Core Surveillance Team. Clin Infect Dis; 2008 Jan 01; 46(1):1-13. PubMed ID: 18171206 [Abstract] [Full Text] [Related]
18. Recent trends in meningococcal epidemiology and current vaccine recommendations. Baltimore RS. Curr Opin Pediatr; 2006 Feb 01; 18(1):58-63. PubMed ID: 16470164 [Abstract] [Full Text] [Related]
19. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Soriano-Gabarró M, Wolter J, Hogea C, Vyse A. Expert Rev Anti Infect Ther; 2011 Sep 01; 9(9):761-74. PubMed ID: 21905785 [Abstract] [Full Text] [Related]
20. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa. Okoko BJ, Idoko OT, Adegbola RA. Vaccine; 2009 Mar 23; 27(14):2023-9. PubMed ID: 19095025 [Abstract] [Full Text] [Related] Page: [Next] [New Search]